If response is inadequate after the FDA-recommended evaluation period at therapeutic doses, consider switching to an alternative agent or referring for surgical revision evaluation in appropriate candidates
As their use expands, questions have emerged about whether GLP-1 medications cause vision problems
It's a reliable support system for many users, helping them stay consistent, reduce cravings, and feel more in control of their health
As we buckle up for another holiday season packed with festivities, family gatherings, and date nights, that bottle of expensive booze youve been saving up for special occasions might get its time to shine
In a drug safety update, published on 28 January 2025, the MHRA cited findings of a recent European Medicines Agency (EMA) review of the available evidence for all GLP-1 and dual GIP/GLP-1 RAs, which concluded that data supports an association between the medicines and the potential risk of pulmonary aspiration during anaesthesia or deep sedation, owing to the delayed gastric emptying linked to these medicines
